AskVantage

Biotech and enhanced humans

Promising ‘Genetic Chainsaw in a pill’ could solve the world’s antibiotic crisis

Bacteria's stellar ability to rapidly evolve to overcome today's most potent antibiotics puts tens of millions of lives at high risk, but now scientists are designing new genetics based antibiotic treatments that could kill off bacteria's natural advantage

Cite or link to this article

Griffin, M. (2017) 'Promising ‘Genetic Chainsaw in a pill’ could solve the world’s antibiotic crisis', 311 Institute, 30 May. Available at: https://www.311institute.com/promising-genetic-chainsaw-in-a-pill-could-solve-the-worlds-antibiotic-crisis/ (Accessed: 1 October 2026).

Even since Alexander Fleming stumbled across penicillin, the first antibiotic drug, scientists knew that our fight with evolution had just begun - they also knew that one day these then advanced medicines would become obsolete. And as anti-biotic resistance increases, as the World Health Organisation (WHO) lists anti-biotic resistance as one of the greatest threats to humanity, capable of increasing the number of deaths around the world by tens of millions of people per year, that day is approaching. Fast.

Most antibiotics work by blocking the biological processes that allow bacteria to thrive and multiply, but with prolonged, low dosage use, antibiotics become a source of stress that prompts the bacteria’s evolutionary DNA machinery to kick in to create new anti-biotic resistant strains, and when one of them becomes resistant they all do.

In one of the most chilling demonstrations you can see this in action in the video below where a single strain of bacteria takes just eleven days to become impervious to doses of anti-biotics that are 1,000 times more powerful than were needed to kill the original bacterial strain.

Watch Bacteria Evolve To Become Resistant To Antibiotics
 

Even worse though, and if all this wasn’t bad enough already, because the same family of anti-biotics generally work on the same biological pathways, when one bacterium evolves a mutation that resists one type of drug, it often renders that entire family of drugs useless.

It’s this arms race that is forcing scientists to think differently.

Now teams of scientists have found a new approach to tackle anti-biotic resistance - a “CRISPR pill” that instructs harmful bacteria to shred their own genes to bits. In short it’s a genetic chainsaw, like the ones I’ve covered before.

In essence, scientists are returning CRISPR, the world’s most powerful real time gene editing tools, to its roots, and while CRISPR’s best known as a handy way to manipulate DNA in anything and everything it turns out that the CRISPR mechanism is actually a part of the bacteria’s natural immune defence system. And just like our immune systems that can turn against themselves, scientists are now hoping to give harmful bacteria a destructive auto-immune disease.

When it’s finished this CRISPR pill, this chainsaw in a capsule, will have the ability, unlike today’s “kill ‘em all” anti-biotics, to precisely target single strains of harmful bacteria, and leave other types, such as the beneficial bacteria in the gut, intact.

This truly is a case of smarter, not stronger.

“The downside of antibiotics is they are a sledgehammer that depletes and destroys the gut microbial community,” says Dr. Jan Peter van Pijkeren at the University of  Wisconsin Madison, who is working on CRISPR based antibiotics, “you want to instead use a scalpel in order to specifically eradicate the microbe of interest.”

“The idea of CRISPR based approaches is to enact sequence-specific antimicrobial activity, placing selective pressure against genes that are bad rather than conserved bacterial targets,” explains Dr. Timothy Lu at MIT who’s leading his own team, “the way I view it is not that we will be able to make an evolution proof therapy, but that the genetic engineering tools will become more robust so that as evolution happens, we can rapidly develop countermeasures.”

FAQ

Why does this matter?

Bacteria's stellar ability to rapidly evolve to overcome today's most potent antibiotics puts tens of millions of lives at high risk, but now scientists are designing new genetics based antibiotic treatments that could kill off bacteria's natural advantage

Matthew Griffin

About the author

Matthew Griffin Founder, 311 Institute

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."

Read full bio

Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.

An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.

As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.

Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.

What future do you need to see?

Choose one to get started on biotech and enhanced humans and the future of your organisation.

Where should Matthew reply?

Takes 30 seconds. No obligation. Matthew replies quickly. Privacy

Tag Cloud

Sources and further reading

  1. World Health Organisation who.int

Source: first published by the 311 Institute on 30 May 2017. Cite as: Griffin, M. (2017). Promising ‘Genetic Chainsaw in a pill’ could solve the world’s antibiotic crisis. 311 Institute. https://www.311institute.com/promising-genetic-chainsaw-in-a-pill-could-solve-the-worlds-antibiotic-crisis/

You are welcome to quote this article with credit and a link to the original.

Book a Keynote